Using genetics and genomics strategies to personalize therapy for cancer: Focus on melanoma
- 20 April 2010
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 80 (5) , 755-761
- https://doi.org/10.1016/j.bcp.2010.04.017
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01 CA114478, P50 CA093372)
This publication has 75 references indexed in Scilit:
- Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAFPublished by Elsevier ,2010
- A comprehensive catalogue of somatic mutations from a human cancer genomeNature, 2009
- Pyrosequencing method to detect KRAS mutation in formalin-fixed and paraffin-embedded tumor tissuesAnalytical Biochemistry, 2009
- AKT-Independent Signaling Downstream of Oncogenic PIK3CA Mutations in Human CancerCancer Cell, 2009
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patientsBritish Journal of Cancer, 2008
- Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or LymphangioleiomyomatosisNew England Journal of Medicine, 2008
- High-throughput oncogene mutation profiling in human cancerNature Genetics, 2007
- Mutations of the BRAF gene in human cancerNature, 2002